5.A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
Weiss EP, Villareal DT, Ehsani AA, Fontana L, Holloszy JO
One year later, participants gained back an average of two-thirds of the weight they lost
In the Phase II obesity clinical trial MOMENTUM-1, a 2.4 mg dose of pemvidutide resulted in an average weight loss of 15.6% after 48 weeks, with the placebo-corrected figure being 13.4%
Por ejemplo, podemos tomarlo antes de una sesin de ejercicio o como parte del desayuno
Newhook TE, Overman MJ, Chun YS, Dasari A, Tzeng CD, Cao HST, Raymond V, Parseghian C, Johnson B, Nishioka Y, Kawaguchi Y, Uppal A, Vreeland TJ, Jaimovich A, Arvide EM, Cristo JV, Wei SH, Raghav KP, Morris VK, Lee JE, Kopetz S , Vauthey JN